TransCardiac Therapeutics

TransCardiac Therapeutics, based in Atlanta, Georgia, was founded in 2003 by Omar Lattouf, MD, PhD, from Emory University. The company focuses on developing innovative technologies that enhance minimally invasive cardiac therapies. Its primary goal is to facilitate access to specific areas within and around the human heart, eliminating the need for large surgical incisions. The technologies developed by TransCardiac Therapeutics allow procedures to be performed without halting the heart's function or utilizing a heart-lung machine, thus aiming to improve patient outcomes and reduce recovery times associated with traditional cardiac surgery.